Patent · US Active

Compounds and methods for IDO and TDO modulation, and indications therefor

US10508085B2 · kind B2 · utility

5Cited by
54References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2017
Grant dateDec 17, 2019
Priority date
Expiry dateSep 22, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula I(a):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.